lansoprazole has been researched along with Laryngeal Diseases in 7 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Laryngeal Diseases: Pathological processes involving any part of the LARYNX which coordinates many functions such as voice production, breathing, swallowing, and coughing.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The association of gastroesophageal reflux disease (GERD) and laryngeal symptoms is not clear." | 2.78 | Is the proton pump inhibitor test helpful in patients with laryngeal symptoms? ( Hong, SN; Kim, JH; Lee, SY; Park, HS; Shim, CS; Sung, IK, 2013) |
| " Results were further analyzed to compare failure rates based on different dosage regimens." | 1.31 | Proton pump inhibitor resistance in the treatment of laryngopharyngeal reflux. ( Amin, MR; Digges, N; Johnson, P; Koufman, JA; Postma, GN, 2001) |
| "Gastroesophageal reflux, common in infants, usually resolves spontaneously by 12 to 18 months." | 1.31 | [Laryngeal manifestations of gastroesophageal reflux disease (GERD) in pediatric patients: the usefulness of therapeutic (proton pump inhibitor (PPI)) trials]. ( Niimi, S; Saigusa, H; Saigusa, U; Yagi, T, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JH | 1 |
| Sung, IK | 1 |
| Hong, SN | 1 |
| Lee, SY | 1 |
| Park, HS | 1 |
| Shim, CS | 1 |
| Lee, YC | 1 |
| Na, SY | 1 |
| Kim, HJ | 1 |
| Yang, CW | 1 |
| Kim, SI | 1 |
| Byun, YS | 1 |
| Jung, AR | 1 |
| Ryu, IY | 1 |
| Eun, YG | 1 |
| Hill, RK | 1 |
| Simpson, CB | 1 |
| Velazquez, R | 1 |
| Larson, N | 1 |
| Silvers, WS | 1 |
| Levine, JS | 1 |
| Poole, JA | 1 |
| Naar, E | 1 |
| Weber, RW | 1 |
| Belafsky, PC | 1 |
| Postma, GN | 2 |
| Koufman, JA | 2 |
| Amin, MR | 1 |
| Johnson, P | 1 |
| Digges, N | 1 |
| Saigusa, H | 1 |
| Niimi, S | 1 |
| Saigusa, U | 1 |
| Yagi, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Placebo-Controlled Assessment of Lansoprazole 30 mg Bid in the Treatment of Gastroesophageal Reflux Associated With Laryngitis[NCT00369265] | Phase 4 | 18 participants (Actual) | Interventional | 2006-08-31 | Terminated (stopped due to Pharmaceutical company purchased by another company and funding was terminated.) | ||
| A Prospective Evaluation of the Utility, Optimal Cutoff and Positive Predictive Value of a Pharyngeal pH Probe for Predicting Proton Pump Inhibitor Response in Treatment Naive Laryngopharyngeal Reflux[NCT01755221] | 80 participants (Anticipated) | Interventional | 2012-08-31 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for lansoprazole and Laryngeal Diseases
| Article | Year |
|---|---|
Is the proton pump inhibitor test helpful in patients with laryngeal symptoms?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Drug Administration Sche | 2013 |
Effect of postoperative proton pump inhibitor therapy on voice outcomes following phonomicrosurgery for vocal fold polyp: a randomized controlled study.
Topics: Adult; Female; Humans; Lansoprazole; Laryngeal Diseases; Laryngoscopy; Male; Microsurgery; Middle Ag | 2016 |
5 other studies available for lansoprazole and Laryngeal Diseases
| Article | Year |
|---|---|
Pachydermia is not diagnostic of active laryngopharyngeal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimid | 2004 |
Inlet patch of gastric mucosa in upper esophagus causing chronic cough and vocal cord dysfunction.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Androstadienes; Anti-Allergic Agents; Cough; Endoscopy, Gas | 2006 |
Laryngopharyngeal reflux symptoms improve before changes in physical findings.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Female; Follow-Up Studie | 2001 |
Laryngopharyngeal reflux symptoms improve before changes in physical findings.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Female; Follow-Up Studie | 2001 |
Laryngopharyngeal reflux symptoms improve before changes in physical findings.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Female; Follow-Up Studie | 2001 |
Laryngopharyngeal reflux symptoms improve before changes in physical findings.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Female; Follow-Up Studie | 2001 |
Proton pump inhibitor resistance in the treatment of laryngopharyngeal reflux.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; | 2001 |
[Laryngeal manifestations of gastroesophageal reflux disease (GERD) in pediatric patients: the usefulness of therapeutic (proton pump inhibitor (PPI)) trials].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Child; Child, Preschool; Gastroesophageal Reflux; Humans; I | 2001 |